Humanwell Healthcare Group Co

Humanwell Healthcare Group Co EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Humanwell Healthcare Group Co (600079.SS) as of Oct 30, 2026 is 18.67. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 30.07 — a change of -37.92% (lower).

EV/FCF

18.67

YoY

-37.92%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Humanwell Healthcare Group Co is 2025 18.67 . EV/FCF (Enterprise Value to Free Cash Flow) of Humanwell Healthcare Group Co was 2024 30.07 . It decreases by -37.92% lower compared to the previous year.

The Humanwell Healthcare Group Co EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-52.50 CNY
Jan 1, 2019
31.84 CNY
Jan 1, 2020
42.82 CNY
Jan 1, 2021
79.40 CNY
Jan 1, 2022
-52.12 CNY
Jan 1, 2023
4,010.83 CNY
Jan 1, 2024
30.07 CNY
Jan 1, 2025
18.67 CNY
The Humanwell Healthcare Group Co EV/FCF history
YEAREV/FCFYoY
18.67-37.92%
30.07-99.25%
4,010.83-7,796.01%
-52.12-165.64%
79.40+85.44%
42.82+34.48%
31.84-160.64%
-52.50+142.03%
-21.69-56.24%
-49.57-20.56%
-62.40-26.23%
-84.59—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Humanwell Healthcare Group Co Stock analysis

What does Humanwell Healthcare Group Co do? Humanwell Healthcare (Group) Co., Ltd. generates revenue through the research and development, production, and sale of a diverse portfolio of medical products. The company’s offerings are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines, and others, alongside the provision of medical instruments. This broad product range allows the firm to serve various healthcare needs across its operational scope. The company distributes its products in both domestic market and to overseas markets, indicating a dual-channel sales strategy that captures value from local and international customers. By engaging in the full lifecycle of medical product creation, from R&D to final sale, Humanwell Healthcare (Group) Co., Ltd. monetizes its extensive capabilities and wide distribution network to drive financial performance. Humanwell Healthcare Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Humanwell Healthcare Group Co stock

EV/FCF (Enterprise Value to Free Cash Flow) of Humanwell Healthcare Group Co is 18.67 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Humanwell Healthcare Group Co changed from 30.07 to 18.67, representing a -37.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Humanwell Healthcare Group Co since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Humanwell Healthcare Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Humanwell Healthcare Group Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Humanwell Healthcare Group Co